PubMed Health⌕ Search

Biomedical subjects

J T McCarthy

Publications and source records attributed to J T McCarthy.

At least 37 records · Page 2Linked to original sources

Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras.

OBJECTIVE: To determine whether any changes occurred in the complexity of illness or survival of Mayo intensive-care unit (ICU) patients with acute renal failure (ARF) who required hemodialysis between the 1977 through 1979 period and the 1991 and 1992 era. DESIGN: A retrospective comparison was done of 71 consecutive ICU patients with ARF during 1977 through 1979 and 71 similar consecutive patients from the 1991 and 1992 period. MATERIAL AND METHODS: Each patient was scored for the three components of the acute physiology and chronic health evaluation (APACHE) II system (acute physiology score, age, and preexisting chronic health problems). Patient gender, postoperative status, presence of diabetes mellitus, presence of chronic renal insufficiency, and factors contributing to ARF were recorded for each patient. Patient survival and renal function at time of hospital dismissal and 12 months after initiation of hemodialysis were determined. RESULTS: In comparison with patients in the earlier study period, those in the later study period had a signficantly improved rate of hospital survival (52% versus 32%) and 1-year survival (30% versus 21%). At 1 year, 96% and 78% of survivors in the earlier and later study groups, respectively, had recovery of renal function. The mean total APACHE II score was the same in both study periods, but patients in the later group were older and had more APACHE II points for chronic health problems. In the earlier and later study groups, patients with an APACHE II score of 21 or lower had a mortality rate of 36% and 11%, respectively, and survival among those with a score of 34 or greater was 0% and 15%, respectively. In 1991 and 1992, more patients had two or more factors contributing to the development of ARF, and intravenous administration of a contrast agent and preexisting cardiac prerenal compromise were more frequent causes of ARF than in 1977 through 1979. The occurrence of sepsis and preexisting lung disease were associated with a dismal prognosis in both study periods. In 1991 and 1992, survival was improved for patients with preexisting diabetes mellitus, postoperative status, and contrast-induced renal failure. CONCLUSION: The prognosis of ICU patients with ARF has improved in more recent years, despite the fact that patients are now older, have more preexisting chronic health conditions, and have an increasing number of conditions contributing to development of ARF. The APACHE II scoring system demonstrated utility for quantifying the complexity of illness in these patients, but several important shortcomings may limit its usefulness as a comparative or prognostic tool in patients with ARF.

APACHE↗

Summer woes.

Explore the source record for details and available documents.

Humans↗

The importance of bone biopsy in managing renal osteodystrophy.

A case is presented in which bone biopsy results helped to resolve not only difficult issues in the clinical management of the patient's renal osteodystrophy but also disruptive psychosocial problems surrounding her clinical course. The outcome was a satisfactory resolution based on rational medical treatment and directed supportive care. The presentation highlights important principles in the procurement, processing, and interpretation of the bone biopsy, while also addressing the importance of accurate diagnosis in facilitating the overall long-term management by the entire renal team.

Aged↗

Prevent cancer.

Explore the source record for details and available documents.

Animals↗

Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism.

BACKGROUND: Parathyromatosis is described by as small nodules of hyperfunctioning parathyroid tissue scattered in the soft tissues of the neck and/or mediastinum. Seeding of hypercellular parathyroid glands during surgical excision and overgrowth of parathyroid rests left behind during ontogenesis are the most likely causes of this rare phenomenon. To characterize the clinical presentation and management of this rare condition, we report on a patient with uremia and persistent hyperparathyroidism occurring after total parathyroidectomy. METHODS: The records of one man with parathyromatosis treated from 1989 to 1993 were reviewed. In addition, a review of the literature was undertaken. RESULTS: Findings at the patient's final operation (a median sternotomy) included multiple nodules of hyperplastic parathyroid tissue scattered throughout the thymus. The characteristics of this histologically benign tissue are consistent throughout various case reports in the literature. CONCLUSIONS: This case presentation shows the physiologic significance of parathyromatosis, particularly in the setting of kidney failure. The importance of meticulous handling of potentially hyperplastic parathyroid glands and routine cervical thymectomy among this subset of patients is emphasized.

Adult↗

Clinical benefits of high and variable sodium concentration dialysate in hemodialysis patients.

Twenty-one hemodialysis patients were studied during 25 dialysis sessions with a dialysate sodium of 140 mEq/L and during 25 sessions with a high and variable sodium dialysate (145 mEq/L decreased to 140 mEq/L). Bicarbonate dialysate and ultrafiltration-controlled dialysis equipment were used. Neither the average interdialytic weight gain nor the predialysis and postdialysis blood pressures changed. The need for 5% saline infusions decreased from 168 + 137 ml/patient to 2 + 6 ml/patient for 25 dialyses. Use of 0.9% saline boluses remain unchanged. Fewer dialysis sessions required the use of the Trendelenburg position (p < .02) or a decrease in the transmembrane pressure (p < .05). With the use of high and variable sodium dialysate concentration, patients had less symptomatic hypotension (p < .05) and fewer symptoms of dialysis dysequilibrium, such as cramps or nausea.

Aged↗

Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.

We retrospectively analyzed serum beta 2-microglobulin (beta 2M) levels in dialysis patients at our institution from 1986 through 1991 to determine the clinical significance of serum beta 2M levels in dialysis patients and to provide further insight into the pathogenesis of beta 2M-associated dialysis arthropathy. We analyzed the relationship between serum beta 2M values can the dialysis modality (hemodialysis and continuous ambulatory peritoneal dialysis [CAPD]), the duration of dialysis therapy, the type of hemodialyzer used, and the level of intrinsic glomerular filtration rate (GFR). The most important relationship observed in all dialysis patients was a significant inverse relationship between intrinsic GFR and serum beta 2M values. For all dialysis patients (hemodialysis and CAPD), serum beta 2M values were highest when the intrinsic GFR was less than 2.1 ml/min. There were no differences in serum beta 2M values between hemodialysis patients and CAPD patients or among patients using different types of cellulose-based hemodialyzers. As patients changed use from cellulose-based dialyzers to polysulfone dialyzers, there was no decline in serum beta 2M values. Exclusive treatment with polysulfone dialyzers for 9 to 12 months after initiation of long-term dialysis also led to no differences in serum beta 2M values compared with those in patients using cellulose-based dialyzers. At very low levels of intrinsic GFR (< 2.1 ml/min), hemodialysis patients using polysulfone dialyzers had lower levels of serum beta 2M than hemodialysis patients using cellulose-based dialyzers; CAPD patients also had lower levels of serum beta 2M than cellulose dialyzer-treated hemodialysis patients when the intrinsic GFR was less than 2.1 ml/min. All hemodialysis patients using cellulose dialyzers and CAPD patients were categorized at last follow-up as having definite, probable, or no evidence of beta 2M-associated dialysis arthropathy on the basis of clinical and radiographic criteria. We noted no significant differences in serum beta 2M values, regardless of the clinical diagnosis with regard to beta 2M-related amyloidosis. Patients with beta 2M amyloidosis had undergone dialysis therapy for a longer duration and had a larger cumulative exposure to beta 2M (the product of average serum beta 2M values and months of dialysis, or "beta 2M-months"). We conclude that the most important determinant of serum beta 2M values in dialysis patients is the remaining level of intrinsic GFR. At extremely low levels of GFR, use of polysulfone dialyzers or CAPD may lead to lower levels of serum beta 2M. Our analysis indicates that the duration of dialysis and cumulative exposure to beta 2M (beta 2M-months) are important factors in the development of clinically evident beta 2M amyloidosis.

Amyloidosis↗

Detection of subtle aluminum-related renal osteodystrophy.

We compared the sensitivity of aurin tricarboxylic acid (ATA) or acid solochrome azurine (ASA) for detecting bone aluminum histochemically in 87 biopsy specimens obtained between 1983 and 1987 from 84 patients receiving dialysis therapy. Two consecutive biopsy sections were stained, one with ATA and the other with ASA, and then interpreted independently by two experienced observers. Three groups were established: group 1 (N = 61) had positive results of both ATA and ASA staining, group 2 (N = 25) had negative ATA but positive ASA sections, and group 3 (N = 1) had negative results of both ATA and ASA. No significant differences existed between groups 1 and 2 for age of the patients or serum calcium or immunoreactive parathyroid hormone levels. Patients in group 1 had significantly higher bone aluminium content (110 versus 61 micrograms/g dry ash weight), higher serum aluminum levels (151 versus 26 ng/ml), and longer duration of dialysis (85 versus 30 months) than did patients in group 2. Bone biopsy diagnoses (group 1 versus group 2) included low-turnover bone disease, 8 versus 7; osteomalacia, 26 versus 0; mixed uremic bone disease, 10 versus 1; hyperparathyroidism, 12 versus 14; and mild uremic bone disease, 5 versus 4. On the basis of ATA staining, 7 of 15 patients with low-turnover and 1 of 11 patients with mixed uremic bone disease may have been incorrectly diagnosed as having non-aluminum-related bone disorders. The levels of bone and serum aluminum were lower in group 2 than in group 1 but still much higher than normal.(ABSTRACT TRUNCATED AT 250 WORDS)

Aluminum↗

Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder.

Myeloid metaplasia associated with idiopathic myelofibrosis most commonly involves the reticuloendothelial organs, such as the spleen, liver and retroperitoneal lymph nodes. We report on a patient with myeloid metaplasia (extramedullary hematopoiesis) of the renal pelves, ureters and bladder. The pathogenesis, clinical characteristics, treatment and prognosis of this condition are discussed.

Adult↗

Sun protection.

Explore the source record for details and available documents.

Humans↗

Hsinchiapo.

Explore the source record for details and available documents.

Criminal Law↗

Two giants.

Explore the source record for details and available documents.

Dermatology↗